Progress in the treatment of neovascular age-related macular degeneration
Age-related macular degeneration(ARMD)is an important cause of visual impairment in people over 65 years old in western countries. It is the third leading cause of blindness in China and mainly affects central visual acuity. Vascular endothelial growth factor(VEGF)plays an important role in the path...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Press of International Journal of Ophthalmology (IJO PRESS)
2021-10-01
|
| Series: | Guoji Yanke Zazhi |
| Subjects: | |
| Online Access: | http://ies.ijo.cn/cn_publish/2021/10/202110014.pdf |
| _version_ | 1818722292201422848 |
|---|---|
| author | Ya-Xin Wang Xiao-Yun Ke Yan-Xia Chen Bin Hu |
| author_facet | Ya-Xin Wang Xiao-Yun Ke Yan-Xia Chen Bin Hu |
| author_sort | Ya-Xin Wang |
| collection | DOAJ |
| description | Age-related macular degeneration(ARMD)is an important cause of visual impairment in people over 65 years old in western countries. It is the third leading cause of blindness in China and mainly affects central visual acuity. Vascular endothelial growth factor(VEGF)plays an important role in the pathogenesis of ARMD. Currently, intravitreous injection of anti-VEGF agents has been considered as the first-line treatment for ARMD. However, some patients still need repeated injection, or response negatively to anti-VEGF agents. Therefore, it is necessary to explore novel therapy to improve clinical outcomes and provide insights for neovascular ARMD treatment. |
| first_indexed | 2024-12-17T20:52:18Z |
| format | Article |
| id | doaj.art-9872a7d4288445f796601fd439d83ce5 |
| institution | Directory Open Access Journal |
| issn | 1672-5123 |
| language | English |
| last_indexed | 2024-12-17T20:52:18Z |
| publishDate | 2021-10-01 |
| publisher | Press of International Journal of Ophthalmology (IJO PRESS) |
| record_format | Article |
| series | Guoji Yanke Zazhi |
| spelling | doaj.art-9872a7d4288445f796601fd439d83ce52022-12-21T21:32:59ZengPress of International Journal of Ophthalmology (IJO PRESS)Guoji Yanke Zazhi1672-51232021-10-0121101732173510.3980/j.issn.1672-5123.2021.10.14202110014Progress in the treatment of neovascular age-related macular degenerationYa-Xin Wang0Xiao-Yun Ke1Yan-Xia Chen2Bin Hu3Department of Ophthalmology, Zhujiang Hospital, Southern Medical University, Guangzhou 510280, Guangdong Province, ChinaDepartment of Ophthalmology, Zhujiang Hospital, Southern Medical University, Guangzhou 510280, Guangdong Province, ChinaDepartment of Ophthalmology, Zhujiang Hospital, Southern Medical University, Guangzhou 510280, Guangdong Province, ChinaDepartment of Ophthalmology, Zhujiang Hospital, Southern Medical University, Guangzhou 510280, Guangdong Province, ChinaAge-related macular degeneration(ARMD)is an important cause of visual impairment in people over 65 years old in western countries. It is the third leading cause of blindness in China and mainly affects central visual acuity. Vascular endothelial growth factor(VEGF)plays an important role in the pathogenesis of ARMD. Currently, intravitreous injection of anti-VEGF agents has been considered as the first-line treatment for ARMD. However, some patients still need repeated injection, or response negatively to anti-VEGF agents. Therefore, it is necessary to explore novel therapy to improve clinical outcomes and provide insights for neovascular ARMD treatment.http://ies.ijo.cn/cn_publish/2021/10/202110014.pdfneovascular age-related macular degenerationvascular endothelial growth factorplatelet derived growth factortherapeutic progress |
| spellingShingle | Ya-Xin Wang Xiao-Yun Ke Yan-Xia Chen Bin Hu Progress in the treatment of neovascular age-related macular degeneration Guoji Yanke Zazhi neovascular age-related macular degeneration vascular endothelial growth factor platelet derived growth factor therapeutic progress |
| title | Progress in the treatment of neovascular age-related macular degeneration |
| title_full | Progress in the treatment of neovascular age-related macular degeneration |
| title_fullStr | Progress in the treatment of neovascular age-related macular degeneration |
| title_full_unstemmed | Progress in the treatment of neovascular age-related macular degeneration |
| title_short | Progress in the treatment of neovascular age-related macular degeneration |
| title_sort | progress in the treatment of neovascular age related macular degeneration |
| topic | neovascular age-related macular degeneration vascular endothelial growth factor platelet derived growth factor therapeutic progress |
| url | http://ies.ijo.cn/cn_publish/2021/10/202110014.pdf |
| work_keys_str_mv | AT yaxinwang progressinthetreatmentofneovascularagerelatedmaculardegeneration AT xiaoyunke progressinthetreatmentofneovascularagerelatedmaculardegeneration AT yanxiachen progressinthetreatmentofneovascularagerelatedmaculardegeneration AT binhu progressinthetreatmentofneovascularagerelatedmaculardegeneration |